Study of Avatrombopag for Temozolomide-induced Thrombocytopenia in Glioma (APATIT-G)

Summary

The purpose of this study is to determine if using avatrombopag in patients with thrombocytopenia due to temozolomide treatment can safely improve a patient's platelet count and allow the patient to complete the temozolomide treatment course as planned.

Timeline

Start

2022-05-06

Primary completion

2023-10-11

Completion

2024-07-18

Drugs

Indications